Skip to content
10-Q

Quarterly Report

CYCLERION THERAPEUTICS, INC. CYCN

0000950170-25-103123

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 3.34M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.84M sh
Shares Diluted Q2 2025 · Jun 30, 2024 2.51M sh
Shares Diluted Q2 2025 · Jun 30, 2024 2.5M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.47M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.98M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.01M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.23M
Stockholders Equity Q2 2025 · Jun 30, 2025 $8.57M
Stockholders Equity Q2 2025 · Dec 31, 2024 $8.85M
Current Liabilities Q2 2025 · Jun 30, 2025 $800K
Current Liabilities Q2 2025 · Dec 31, 2024 $725K
Current Assets Q2 2025 · Jun 30, 2025 $4.02M
Current Assets Q2 2025 · Dec 31, 2024 $4.23M
Total Assets Q2 2025 · Jun 30, 2025 $9.37M
Total Assets Q2 2025 · Dec 31, 2024 $9.58M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.62
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.53
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.14
Eps Basic Q2 2025 · Jun 30, 2025 −$0.11
Eps Basic Q2 2025 · Jun 30, 2025 −$0.62
Eps Basic Q2 2025 · Jun 30, 2024 −$0.53
Eps Basic Q2 2025 · Jun 30, 2024 −$1.14
Sga Expense Q2 2025 · Jun 30, 2025 $1.71M
Sga Expense Q2 2025 · Jun 30, 2025 $3.21M
Sga Expense Q2 2025 · Jun 30, 2024 $1.28M
Sga Expense Q2 2025 · Jun 30, 2024 $2.85M
Rd Expense Q2 2025 · Jun 30, 2025 $56K
Rd Expense Q2 2025 · Jun 30, 2025 $92K
Rd Expense Q2 2025 · Jun 30, 2024 $105K
Rd Expense Q2 2025 · Jun 30, 2024 $149K
Net Income Q2 2025 · Jun 30, 2025 −$324K
Net Income Q2 2025 · Jun 30, 2025 −$1.75M
Net Income Q2 2025 · Mar 31, 2025 −$1.43M
Net Income Q2 2025 · Jun 30, 2024 −$1.32M
Net Income Q2 2025 · Jun 30, 2024 −$2.86M
Net Income Q2 2025 · Mar 31, 2024 −$1.54M
Operating Income Q2 2025 · Jun 30, 2025 −$1.67M
Operating Income Q2 2025 · Jun 30, 2025 −$3.13M
Operating Income Q2 2025 · Jun 30, 2024 −$1.38M
Operating Income Q2 2025 · Jun 30, 2024 −$3M